As of January 22, 2025, G1 Therapeutics (GTHX) has a market cap of $0.38 billion USD. According to our data, G1 Therapeutics is ranked No.6442 in global market value.
Year | Market Cap | %Change |
---|---|---|
Sep 18, 2024 | $0.38 B |
134.43%
|
Dec 29, 2023 | $0.16 B |
-43.83%
|
Dec 30, 2022 | $0.29 B |
-46.82%
|
Dec 31, 2021 | $0.54 B |
-43.25%
|
Dec 31, 2020 | $0.95 B |
-31.93%
|
Dec 31, 2019 | $1.39 B |
38.02%
|
Dec 31, 2018 | $1.01 B |
-3.48%
|
Dec 29, 2017 | $1.05 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
Market Cap | = | GTHX Stock Price | * | GTHX Shares Outstanding |
= | $7.15 | * | 52.76 M | |
= | $0.38 B |